Long-term use of a product containing N-nitroso-quinapril may be associated with an increased cancer risk based on data from closely related nitrosamine compounds. Aurobindo Pharma USA has voluntarily ...

Glenmark Pharmaceuticals Inc. in Elmwood Park, N.J., is recalling the pills, which are in 2.5 mg and 6.25 mg doses.

(RTTNews) - Aurobindo Pharma USA, Inc., affiliated to Indian pharma major Aurobindo Pharma Limited, is recalling two lots of Quinapril and Hydrochlorothiazide tablets due to the presence of ...

RALEIGH, N.C., April 1, 2026 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the re‑launch of ...

Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and ...

RECALLED Irbesartan-and hydrochlorothiazide lots. Lupin N-nitroso-irbesartan is a probable human carcinogen based on results from laboratory tests. Lupin Pharmaceuticals is voluntarily recalling all ...

Eleven lots of blood pressure medication quinapril and quinapril HCI/hydrochlorothiazide made by Pfizer and sold under a brand name and distributed as authorized generics have been recalled. Six lots ...

The latest blood pressure medication recall comes from Aurobindo Pharma, which yanked two lots of Quinapril and Hydrochlorothiazide tablets for having too much of the nitrosamine impurity ...

NEW YORK (WFXR) – Pfizer has issued a nationwide recall of some blood pressure medications due to the presence of nitrosamine above the Acceptable Daily Intake (ADI) level. The recall, announced this ...

Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...